We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Sekisui Diagnostics UK Ltd.

Download Mobile App




AI Tool Helps Clinicians Prescribe Right Dose of Warfarin to Heart Surgery Patients

By HospiMedica International staff writers
Posted on 14 Mar 2024
Print article
Image: AI can help decide the right dose for prescribing warfarin to heart surgery patients (Photo courtesy of Tatiana Shepeleva/Shutterstock)
Image: AI can help decide the right dose for prescribing warfarin to heart surgery patients (Photo courtesy of Tatiana Shepeleva/Shutterstock)

Warfarin, a widely used oral anticoagulant, requires personalized dosing for each patient following heart surgery, unlike other drugs which have a standard adult dosage. The dosage determination depends on the International Normalized Ratio (INR) test, a blood test that gauges the blood's clotting time. Achieving the appropriate warfarin dosage is critical; too low a dose could lead to clot formation, whereas too high a dose increases the risk of internal bleeding or other serious complications. Frequent INR monitoring is essential post-initiation of warfarin therapy to assess the patient's drug response. The warfarin dose is then adjusted based on achieving a therapeutic INR range. This dosage adjustment process continues until the desired INR range is attained. However, finding the correct warfarin dose can be challenging due to the multitude of factors influencing its effectiveness, including genetic makeup, kidney and liver function, and the timing of drug initiation post-surgery. Until now, clinicians had to manually consider all these variables for determining the patient's dose. But now, a new artificial intelligence (AI) tool can automatically account for them and calculate a dose for use as a reference.

The AI tool developed by a group of researchers at St. Michael’s Hospital (Toronto, Canada) can help clinicians prescribe warfarin to heart surgery patients by guiding their use of the blood thinner medication. The tool was developed using data from more than 1,000 heart surgery patients who were administered warfarin that included variables such as patient characteristics, health conditions, individual warfarin doses, and response to the anticoagulant. The tool was then tested using a second set of data and validated for accuracy. The tool incorporates two validated AI models: one for predicting the warfarin dose in patients undergoing mechanical valve replacement, and another for dosing in all other heart surgery patients. This AI tool is currently in use at St. Michael’s Hospital, where it has received positive feedback from clinicians.

“People talk about the art of dosing, and some clinicians have a knack for it. But the nice thing about this tool is that it’s an extra layer of validation for patients for whom we’re struggling to get the right dose,” said Lindsay Dryden, St. Michael’s Hospital clinical pharmacist. “It’s something that clinicians can hang their hat on and that gives them a bit more confidence.”

“It’s a predictive tool that’s based off retrospective data – so if a patient comes in with similar characteristics and variables of past patients, we can predict how they might respond to a similar warfarin dose,” added Jacquelin Song, interim manager of Practice Innovation and Change. “This is an extra tool to help support clinical decision-making, almost like a second opinion.”

Related Links:
St. Michael’s Hospital

Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Silver Member
Compact 14-Day Uninterrupted Holter ECG
NR-314P
New
Hysteroscopic Fluid Management System
HysteroFlow/HysteroBalance II

Print article

Channels

Critical Care

view channel
Image: This study is significant as it addresses a treatment approach that has not been extensively studied before (Photo courtesy of 123RF)

Study Confirms Safety of DCB-Only Strategy for Treating De Novo Left Main Coronary Artery Disease

There has been a lack of extensive research on the use of drug-coated balloon (DCB)-only strategy for the treatment of de novo left main coronary artery disease, especially in high bleeding risk (HBR) patients.... Read more

Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The Quantra Hemostasis System has received US FDA special 510(k) clearance for use with its Quantra QStat Cartridge (Photo courtesy of HemoSonics)

Critical Bleeding Management System to Help Hospitals Further Standardize Viscoelastic Testing

Surgical procedures are often accompanied by significant blood loss and the subsequent high likelihood of the need for allogeneic blood transfusions. These transfusions, while critical, are linked to various... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.